High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study
Background: Primary percutaneous coronary intervention (PCI) has been shown to be an effective therapy for patients with acute myocardial infarction (MI). Glycoprotein (GP) IIb/IIIa receptor blockers reduce thrombotic complications in patients undergoing PCI. Most available data relate to Reopro, wh...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Medknow Publications
2012-01-01
|
| シリーズ: | Heart Views |
| 主題: | |
| オンライン･アクセス: | http://www.heartviews.org/article.asp?issn=1995-705X;year=2012;volume=13;issue=3;spage=85;epage=90;aulast=Balghith |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|